These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 18537540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acetylcholinesterase (AChE)--amyloid-beta-peptide complexes in Alzheimer's disease. the Wnt signaling pathway.
    Inestrosa NC, Urra S, Colombres M.
    Curr Alzheimer Res; 2004 Nov; 1(4):249-54. PubMed ID: 15975054
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D, Mazzaro N, Canale C, Gasparini L.
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [Abstract] [Full Text] [Related]

  • 5. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z, Jackson RJ, Hong W, Taylor WM, Corbett GT, Moreno A, Liu W, Li S, Frosch MP, Slutsky I, Young-Pearse TL, Spires-Jones TL, Walsh DM.
    J Neurosci; 2017 Dec 06; 37(49):11947-11966. PubMed ID: 29101243
    [Abstract] [Full Text] [Related]

  • 6. Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target.
    Inestrosa NC, Varela-Nallar L, Grabowski CP, Colombres M.
    IUBMB Life; 2007 Dec 06; 59(4-5):316-21. PubMed ID: 17505971
    [Abstract] [Full Text] [Related]

  • 7. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC, Weinstein D, Monasterio O, Inestrosa NC.
    Biochemistry; 2011 Sep 27; 50(38):8127-37. PubMed ID: 21838267
    [Abstract] [Full Text] [Related]

  • 8. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T.
    Brain Nerve; 2010 Jul 27; 62(7):691-9. PubMed ID: 20675873
    [Abstract] [Full Text] [Related]

  • 9. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
    De Ferrari GV, Chacón MA, Barría MI, Garrido JL, Godoy JA, Olivares G, Reyes AE, Alvarez A, Bronfman M, Inestrosa NC.
    Mol Psychiatry; 2003 Feb 27; 8(2):195-208. PubMed ID: 12610652
    [Abstract] [Full Text] [Related]

  • 10. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S, Jin M, Liu L, Dang Y, Ostaszewski BL, Selkoe DJ.
    Acta Neuropathol Commun; 2018 Nov 08; 6(1):121. PubMed ID: 30409172
    [Abstract] [Full Text] [Related]

  • 11. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ, Staniszewski A, To L, Fa M, Teich AF, Saeed F, Wostein H, Walko T, Vaswani A, Wardius M, Syed Z, Ravenscroft J, Mozzoni K, Silky C, Rehak C, Yurko R, Finn P, Look G, Rishton G, Safferstein H, Miller M, Johanson C, Stopa E, Windisch M, Hutter-Paier B, Shamloo M, Arancio O, LeVine H, Catalano SM.
    PLoS One; 2014 Nov 08; 9(11):e111898. PubMed ID: 25390368
    [Abstract] [Full Text] [Related]

  • 12. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.
    Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E.
    Acta Neuropathol; 2010 May 08; 119(5):523-41. PubMed ID: 20354705
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotective Effects of Ferruginol, Jatrophone, and Junicedric Acid Against Amyloid-β Injury in Hippocampal Neurons.
    Zolezzi JM, Lindsay CB, Serrano FG, Ureta RC, Theoduloz C, Schmeda-Hirschmann G, Inestrosa NC.
    J Alzheimers Dis; 2018 May 08; 63(2):705-723. PubMed ID: 29660932
    [Abstract] [Full Text] [Related]

  • 14. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A, Capetillo-Zarate E, Kosterin I, Abramowski D, Kumar S, Yamaguchi H, Walter J, Fändrich M, Staufenbiel M, Thal DR.
    Neurobiol Aging; 2012 Nov 08; 33(11):2641-60. PubMed ID: 22305478
    [Abstract] [Full Text] [Related]

  • 15. Alzheimer's disease.
    De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.
    Subcell Biochem; 2012 Nov 08; 65():329-52. PubMed ID: 23225010
    [Abstract] [Full Text] [Related]

  • 16. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J.
    Am J Pathol; 1999 Sep 08; 155(3):853-62. PubMed ID: 10487842
    [Abstract] [Full Text] [Related]

  • 17. In vivo localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease.
    Jean L, Brimijoin S, Vaux DJ.
    J Biol Chem; 2019 Apr 19; 294(16):6253-6272. PubMed ID: 30787102
    [Abstract] [Full Text] [Related]

  • 18. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
    Izzo NJ, Xu J, Zeng C, Kirk MJ, Mozzoni K, Silky C, Rehak C, Yurko R, Look G, Rishton G, Safferstein H, Cruchaga C, Goate A, Cahill MA, Arancio O, Mach RH, Craven R, Head E, LeVine H, Spires-Jones TL, Catalano SM.
    PLoS One; 2014 Apr 19; 9(11):e111899. PubMed ID: 25390692
    [Abstract] [Full Text] [Related]

  • 19. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C, Inestrosa NC.
    J Neurochem; 2018 Feb 19; 144(4):443-465. PubMed ID: 29240990
    [Abstract] [Full Text] [Related]

  • 20. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease.
    Ryan TM, Roberts BR, McColl G, Hare DJ, Doble PA, Li QX, Lind M, Roberts AM, Mertens HD, Kirby N, Pham CL, Hinds MG, Adlard PA, Barnham KJ, Curtain CC, Masters CL.
    J Neurosci; 2015 Feb 18; 35(7):2871-84. PubMed ID: 25698727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.